Colorectal cancer
A novel combination therapy of garsorasib and cetuximab for KRAS G12C mutated colorectal cancer patients
Anika Sharma
D‐1553 is a small-molecule inhibitor designed to selectively target KRAS G12C and is currently undergoing Phase II clinical trials. It ...
Lonsurf gets a boost from FDA for colorectal cancer, challenging rivals Takeda and Hutchmed
SG Tylor
Source – Taiho Oncology Eight years after initially gaining FDA approval for the treatment of heavily pretreated colorectal cancer, Taiho ...
